| 14.19 Data as of 3:59pm ET |  +0.43 / +3.12%Today’s Change | 9.86 Today|||52-Week Range 31.21 | +5.74% Year-to-Date |
| Senators Carper, Murkowski, Representatives Cassidy, Kind Introduce Bill to Help Redu... 1:26pm / Benzinga | VIVUS Study Shows STENDRA is Effective for Sexual Activity Within 15 Minutes in Men W... 7:21am / Benzinga |
| StreetInsider.com Pre-Open Movers 6/19: (PLX) (CYTK) (ADBE) Higher; (OSH) (VNDA) (TTE... 11:27am / Investing Channel | Consumer Reports Says "Exercise" Rather Than Take This Drug Jun 17 / MotleyFool.com |
| StreetInsider.com Pre-Open Movers 6/19: (PLX) (CYTK) (ADBE) Higher; (OSH) (VNDA) (TTE... 11:27am / Investing Channel | VIVUS Tells Holders to Support Board, Management Team Jun 17 / Benzinga |
| 2 Biotech Approval Outcomes That Might Affect You 10:06am / MotleyFool.com | The Obesity-Drug Wars Officially Begin Jun 12 / MotleyFool.com |
| VIVUS Reports Study Results Demonstrating STENDRA Effective for Sexual Activity withi... 7:21am / Benzinga | An Obesity Drug Stock to Fatten your Portfolio? Jun 10 / MotleyFool.com |
| Previous close | 13.76 |
| Today’s open | 14.25 |
| Day’s range | 13.74 - 14.90 |
| Volume | 5,865,692 |
| Average volume (3 months) | 2,197,335 |
| Market cap | $1.4B |
| Dividend yield | -- |
| Earnings growth (last year) | -158.18% |
| Earnings growth (this year) | -33.40% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 655.59 |
| Price/Book | 6.21 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACORAcorda Therapeutics ... | -0.11 | -0.31% |
| SNTSSantarus Inc | -0.69 | -3.10% |
| AKRXAkorn Inc | -0.25 | -1.85% |
| IPXLImpax Laboratories I... | -0.33 | -1.75% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $2.0M |
| Annual profit (last year) | -$139.9M |
| Net profit margin | -6,944.98% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President & Director Peter Y. Tam, MBA |
Chief Executive Officer & Director Leland F. Wilson |
Corporate headquarters Mountain View, California |
.
